Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYCN | AZN | AMGN | GILD | BMY |
| Company | Cyclerion Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.09 | 186.69 | 336.26 | 133.77 | 56.69 |
| High | 3.20 | 186.70 | 337.94 | 134.65 | 57.05 |
| Low | 3.07 | 184.70 | 333.47 | 131.81 | 56.10 |
| Latest | 3.18 | 185.52 | 335.74 | 132.48 | 56.70 |
| Change | +0.05 | -2.20 | -0.71 | -0.57 | +0.31 |
| % Change | +1.60% | -1.17% | -0.21% | -0.43% | +0.55% |
| Volume | 105,919 | 740,799 | 951,803 | 1,878,856 | 3,808,875 |
| 20-Day Average Volume | 115,643 | 2,049,416 | 2,637,261 | 6,126,789 | 9,986,188 |
| Previous Close | 3.13 | 187.72 | 336.45 | 133.05 | 56.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.12 | 188.21 | 338.33 | 132.68 | 57.80 |
| 20-Day Raw Stochastic | 53.74% | 21.50% | 41.59% | 37.33% | 21.98% |
| 20-Day Relative Strength | 55.25 | 44.26 | 44.95 | 44.53 | 44.86 |
| Weighted Alpha | -44.95 | +27.98 | +18.54 | +23.18 | +20.78 |
| Today's Opinion | 88% Buy | 16% Sell | 24% Sell | 8% Sell | 8% Buy |
| Previous Opinion | 88% Buy | 8% Buy | 24% Sell | 24% Buy | 16% Buy |
| Last Month's Opinion | 72% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.27% since 05/07/26 | +1.60% since 05/07/26 | +1.99% since 05/07/26 | -1.41% since 05/07/26 | +0.60% since 05/07/26 |
| Low | 3.04 on 05/11/26 | 181.58 on 05/08/26 | 327.62 on 05/11/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 3.22 on 05/13/26 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.03 on 05/14/26 |
| 1-Month | |||||
| %Chg | -0.93% since 04/14/26 | -9.27% since 04/14/26 | -4.36% since 04/14/26 | -5.90% since 04/14/26 | -2.57% since 04/14/26 |
| Low | 2.83 on 04/17/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 3.50 on 04/29/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +155.20% since 02/13/26 | -9.78% since 02/13/26 | -9.08% since 02/13/26 | -14.72% since 02/13/26 | -6.84% since 02/13/26 |
| Low | 1.16 on 02/17/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 8.48 on 04/01/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +134.56% since 11/14/25 | +4.06% since 11/14/25 | -0.32% since 11/14/25 | +5.72% since 11/14/25 | +21.30% since 11/14/25 |
| Low | 1.03 on 02/09/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 8.48 on 04/01/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,554 | 291,136,448 | 181,577,024 | 165,190,896 | 115,152,384 |
| Shares Outstanding, K | 4,330 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 2,070,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -3,530,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,030,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -800,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.80 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 03/30/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/04/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.93 | 15.22 | 16.12 | 9.52 |